Fournier's gangrene

From Aaushi
Jump to navigation Jump to search

Etiology

Epidemiology

  • rare
  • incidence is increasing with an ageing population

Pathology

Clinical manifestations

Management

prognosis:

  • with aggressive early surgical management, survival rates may be >70%

More general terms

References

  1. Pais VM, Schwartz BF eMedicine: Fournier gangrene http://emedicine.medscape.com/article/2028899-overview
  2. Thwaini A, Khan A, Malik A et al Fournier's gangrene and its emergency management. Postgrad Med J. 2006 Aug; 82(970): 516-519. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/16891442 <Internet> http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2585703/
  3. 3.0 3.1 Bersoff-Matcha SJ, Chamberlain C, Cao C et al Fournier Gangrene Associated With Sodium-Glucose Cotransporter-2 Inhibitors: A Review of Spontaneous Postmarketing Cases. Ann Intern Med. 2019. May 7 PMID: https://www.ncbi.nlm.nih.gov/pubmed/31060053 https://annals.org/aim/article-abstract/2732837/fournier-gangrene-associated-sodium-glucose-cotransporter-2-inhibitors-review-spontaneous
  4. 4.0 4.1 Voelzke BB, Hagedorn JC. Presentation and Diagnosis of Fournier Gangrene. Urology. 2018 Apr;114:8-13 PMID: https://www.ncbi.nlm.nih.gov/pubmed/29146218 Review.
  5. NEJM Knowledge+ Endocrinology